tradingkey.logo
tradingkey.logo
Buscar

AngioDynamics Inc

ANGO
Añadir a la lista de seguimiento
13.090USD
+0.010+0.08%
Cierre 07/02, 13:00ETCotizaciones retrasadas 15 min
545.62MCap. mercado
PérdidaP/E TTM

Más Datos de AngioDynamics Inc Compañía

AngioDynamics, Inc. is a transformative medical technology company. The Company is focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving quality of life for patients. It designs, manufactures, and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Its devices are generally used in minimally invasive, image-guided procedures. Its segments include Med Tech and Med Device. Its product categories include oncology, venous therapies, vascular interventions, and ports. Its oncology products include Model 1500X RF Generator, IsoLoc Endorectal Balloon, Habib 4X Laparoscopic Bipolar Resection Device, Habib 4X Bipolar Resection Device, and Alatus. Its venous therapies include VenaCure EVLT 1470 Pro Laser, VenaCure EVLT System, VenaCure EVLT Procedure Packs, and others.

Información de AngioDynamics Inc

Símbolo de cotizaciónANGO
Nombre de la empresaAngioDynamics Inc
Fecha de salida a bolsaMay 27, 2004
Director ejecutivoClemmer (James C)
Número de empleados675
Tipo de seguridadOrdinary Share
Fin del año fiscalMay 27
Dirección14 Plaza Drive
CiudadLATHAM
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal12110
Teléfono15187981215
Sitio Webhttps://www.angiodynamics.com/
Símbolo de cotizaciónANGO
Fecha de salida a bolsaMay 27, 2004
Director ejecutivoClemmer (James C)

Ejecutivos de AngioDynamics Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Stephen A. Trowbridge, J.D.
Mr. Stephen A. Trowbridge, J.D.
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
323.32K
+0.28%
Mr. Howard W. Donnelly
Mr. Howard W. Donnelly
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
167.05K
--
Ms. Eileen O'Shea Auen
Ms. Eileen O'Shea Auen
Independent Director
Independent Director
129.72K
--
Ms. Laura Piccinini
Ms. Laura Piccinini
Senior Vice President, General Manager - Endovascular Therapies and International
Senior Vice President, General Manager - Endovascular Therapies and International
102.52K
-35.34%
Mr. Wesley E. Johnson, Jr.
Mr. Wesley E. Johnson, Jr.
Independent Director
Independent Director
--
--
Mr. James C. Clemmer
Mr. James C. Clemmer
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Ms. Jan Stern Reed
Ms. Jan Stern Reed
Independent Director
Independent Director
--
--
Mr. Warren G. Nighan
Mr. Warren G. Nighan
Senior Vice President - Global Supply Chain, Quality and Regulatory Affairs
Senior Vice President - Global Supply Chain, Quality and Regulatory Affairs
--
--
Mr. Chad T. Campbell
Mr. Chad T. Campbell
Senior Vice President, General Manager - Global Oncology and Vascular Access
Senior Vice President, General Manager - Global Oncology and Vascular Access
--
--
Ms. Karen A. Licitra
Ms. Karen A. Licitra
Independent Director
Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Stephen A. Trowbridge, J.D.
Mr. Stephen A. Trowbridge, J.D.
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
323.32K
+0.28%
Mr. Howard W. Donnelly
Mr. Howard W. Donnelly
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
167.05K
--
Ms. Eileen O'Shea Auen
Ms. Eileen O'Shea Auen
Independent Director
Independent Director
129.72K
--
Ms. Laura Piccinini
Ms. Laura Piccinini
Senior Vice President, General Manager - Endovascular Therapies and International
Senior Vice President, General Manager - Endovascular Therapies and International
102.52K
-35.34%
Mr. Wesley E. Johnson, Jr.
Mr. Wesley E. Johnson, Jr.
Independent Director
Independent Director
--
--
Mr. James C. Clemmer
Mr. James C. Clemmer
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--

Preguntas frecuentes

¿Quiénes son los cinco principales accionistas de AngioDynamics Inc?

Los cinco principales accionistas de AngioDynamics Inc son: Mr. Stephen A. Trowbridge, J.D.

¿Cuántas instituciones poseen acciones de AngioDynamics Inc (ANGO)?

A fecha de 2026Q1, 321 instituciones poseen acciones de AngioDynamics Inc, con un valor de mercado combinado de aproximadamente 38.82M, lo que representa el 93.94% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -7218201.00.